These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16199376)

  • 1. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
    Schnyder A; Krähenbühl S; Drewe J; Huwyler J
    J Drug Target; 2005 Jun; 13(5):325-35. PubMed ID: 16199376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain drug delivery of small molecules using immunoliposomes.
    Huwyler J; Wu D; Pardridge WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14164-9. PubMed ID: 8943078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
    Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
    J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
    Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
    Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. By-passing of P-glycoprotein using immunoliposomes.
    Huwyler J; Cerletti A; Fricker G; Eberle AN; Drewe J
    J Drug Target; 2002 Feb; 10(1):73-9. PubMed ID: 11996089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug targeting using OX7-immunoliposomes: correlation between Thy1.1 antigen expression and tissue distribution in the rat.
    Tuffin G; Huwyler J; Waelti E; Hammer C; Marti HP
    J Drug Target; 2008 Feb; 16(2):156-66. PubMed ID: 18274936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of daunomycin and adriamycin encapsulated in immunoliposomes against avian myeloblastosis virus-infected cells.
    Dhananjaya KV; Antony A
    J Virol Methods; 1988 Feb; 19(2):131-40. PubMed ID: 2452826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
    Gosk S; Vermehren C; Storm G; Moos T
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells.
    Somjen D; Stern N; Knoll E; Sharon O; Gayer B; Kulik T; Kohen F
    J Endocrinol; 2003 Dec; 179(3):395-403. PubMed ID: 14656209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual ligand immunoliposomes for drug delivery to the brain.
    Loureiro JA; Gomes B; Fricker G; Cardoso I; Ribeiro CA; Gaiteiro C; Coelho MA; Pereira Mdo C; Rocha S
    Colloids Surf B Biointerfaces; 2015 Oct; 134():213-9. PubMed ID: 26204501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel immunoliposome mediated by CD123 antibody targeting to acute myeloid leukemia cells.
    Wang Y; Liu F; Wang Q; Xiang H; Jin H; Li H; Mao S
    Int J Pharm; 2017 Aug; 529(1-2):531-542. PubMed ID: 28583331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
    Wu D; Song BW; Vinters HV; Pardridge WM
    J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes Coloaded with Elacridar and Tariquidar To Modulate the P-Glycoprotein at the Blood-Brain Barrier.
    Nieto Montesinos R; Béduneau A; Lamprecht A; Pellequer Y
    Mol Pharm; 2015 Nov; 12(11):3829-38. PubMed ID: 26390138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.